Primary Care Survey of Cancer MDT |
In April this year, a group of Medical Professionals from hospitals in London and beyond, recognising the disruption that the Pandemic was causing in the lives and care of those diagnosed with cancer, set out to find a way to improve the realities which they and their colleagues are facing.
Working with patients, PREVAIL was developed. This will essentially change the way hospitals prioritise patients for their cancer treatment, based on their tumour type and risk. Although it was developed to improve services in the grip of COVID 19, the aim has been to create a pathway which makes life better for people presenting with cancer and in the process make the pathway easier for primary care to manage their patients’ expectations.
Hospitals will share the MDT notes with GPs immediately after the discussion so primary care are aware of the decisions being made, which will improve communication between primary and secondary care at a key point in the patient’s pathway and shorten the time and workload at no increase in cost/resources. A sample of the MDT proforma is on page 3 of the linked Primary Care summary pack
This could be quite a big change to the way things are done. It has been developed for colorectal cancer, but similar processes can be used for other tumour types, and so it would be good to get this right at the outset.
The PREVAIL Pathway is at a very important stage of its development and is currently being piloted in a number of hospitals. The project would very much benefit from your input at this stage, in the assessment of how much more this would improve the primary care aspect for your patients.
It would be great to get your thoughts on the process. We really appreciate your time and feedback.
Working with patients, PREVAIL was developed. This will essentially change the way hospitals prioritise patients for their cancer treatment, based on their tumour type and risk. Although it was developed to improve services in the grip of COVID 19, the aim has been to create a pathway which makes life better for people presenting with cancer and in the process make the pathway easier for primary care to manage their patients’ expectations.
Hospitals will share the MDT notes with GPs immediately after the discussion so primary care are aware of the decisions being made, which will improve communication between primary and secondary care at a key point in the patient’s pathway and shorten the time and workload at no increase in cost/resources. A sample of the MDT proforma is on page 3 of the linked Primary Care summary pack
This could be quite a big change to the way things are done. It has been developed for colorectal cancer, but similar processes can be used for other tumour types, and so it would be good to get this right at the outset.
The PREVAIL Pathway is at a very important stage of its development and is currently being piloted in a number of hospitals. The project would very much benefit from your input at this stage, in the assessment of how much more this would improve the primary care aspect for your patients.
It would be great to get your thoughts on the process. We really appreciate your time and feedback.
Thank you